Unicorns Podcast: Control Bionics (ASX CBL) leading the world in life-changing technology
Health & Biotech
Health & Biotech
The Unicorns Podcast connects you to some of the best and brightest founders, CEOs, executives, business owners, innovators, entrepreneurs and inspiring leaders who make things happen and inspire others.
Host Justin Kelly, former broadcast journalist and PR veteran, chats with leaders from across Australia and internationally on business strategy; what it takes to build a successful company; how to overcome challenges, and advice for those on a similar journey.
On this episode, Justin talks with Jeremy Steele, CEO of Control Bionics (ASX:CBL).
Control Bionics is a medical device company assisting patients whose ability to communicate verbally or via text and social media is compromised by illnesses such as Motor Neurone Disease (MND) and Amyotrophic Lateral Sclerosis (ALS).
Control Bionics operates in North America, Australia, Singapore and Japan. It creates life-changing, single and multi-modal solutions designed for those living with motor impairment and speech difficulties.
It recently launched the world’s first autonomous driving wheelchair module. The ground-breaking DROVE module was created in collaboration with Deakin University’s Applied AI Institute (A2I2). The Australian manufactured tech can be retro-fitted to powered wheelchairs and allows users to move their chair autonomously and precisely without a joystick, to specific locations within the home – a world first.
DROVE uses a digital camera system with Control Bionics tracking software and NeuroNode technology which allows users to control an interface using only neural signals.
To hear more, click below;